IFNA1 and hepatocellular carcinoma: Splenocytes from mice treated with VSV-Lcn2 + anti-PD-L1, showed a trend towards a recall Th-1 response against live SB-HCC 1,2,3 explants but this did not reach significance compared to splenocytes from mice treated with VSV-IFNß + anti-PD-L1 (Fig. 6C).